The Federal Trade Commission has temporarily suspended its lawsuit against Amgen and Horizon Therapeutics seeking to block the multi-billion dollar merger between the two companies, according to a court filing posted late Friday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,